rs13207033 — TNFAIP3

TNFAIP3 6q23 — A Genetic Edge Against Autoimmune Disease

The 6q23 chromosomal region harbors one of the strongest known genetic influences on autoimmune disease risk. Most people know of this locus through its risk variants — but rs13207033 tells the other side of the story. This intergenic SNP, located near the TNFAIP3 gene on chromosome 6, tags a protective haplotype¹¹ protective haplotype
A haplotype is a set of alleles inherited together on the same chromosome; rs13207033 marks a chromosomal block associated with higher TNFAIP3 activity that appears to enhance the activity of A20, the immune system's primary brake on NF-kB-driven inflammation. Carriers of the A allele show meaningfully reduced risk for rheumatoid arthritis, particularly in the autoantibody-positive form that causes the most destructive joint disease.

TNFAIP3 encodes A20, a ubiquitin-editing enzyme²² ubiquitin-editing enzyme
A20 uses two functional domains: a deubiquitinase that removes activating ubiquitin chains and an E3 ligase that adds inhibitory chains, together terminating NF-kB signal transduction that terminates NF-kB inflammatory signaling after an immune response has served its purpose. Without sufficient A20 activity, inflammatory signals persist and self-reactive immune responses become more likely — the fundamental mechanism underlying most autoimmune diseases.

The Mechanism

rs13207033 is located in the intergenic region near TNFAIP3 on chromosome 6q23.3, in a ~60-kb stretch between the OLIG3 and TNFAIP3 genes that does not encode any transcripts. It does not alter any protein directly; instead, it tags a regulatory haplotype³³ regulatory haplotype
A haplotype block in high linkage disequilibrium with rs13207033, meaning these alleles travel together across generations that appears to increase TNFAIP3 expression or enhance A20 function. The SNP is in perfect linkage disequilibrium⁴⁴ linkage disequilibrium
LD means the alleles co-occur more frequently than chance would predict, so rs13207033 and rs10499194 are essentially interchangeable markers for the same protective haplotype (r² = 1) with rs10499194, the variant more frequently tested in Asian-population studies. Carriers of the rs10499194 T allele (which perfectly tags the rs13207033 A allele) express higher levels of A20 mRNA, providing a plausible mechanism for the observed protective effect.

The consequence of enhanced A20 expression is more efficient termination of NF-kB signaling cascades. When the immune system encounters an antigen, NF-kB drives cytokine production and T-cell activation. A20 shuts this process down once the threat is cleared. Higher A20 expression means inflammatory responses resolve more completely, reducing the probability that immune activation becomes chronic and self-directed.

The Evidence

The protective nature of rs13207033 was established through conditional logistic regression⁵⁵ conditional logistic regression
A statistical method that identifies whether a variant remains independently significant after accounting for the effects of other nearby variants fine-mapping of the 6q23 locus. After accounting for the known risk variants rs6920220 and rs5029937, rs13207033 remained independently associated with RA protection (OR 0.86, 95% CI 0.80–0.93, P=0.0001) in 3,962 RA patients and 3,531 controls from six UK centers.

The protective effect is most pronounced in ACPA-positive RA⁶⁶ ACPA-positive RA
ACPA stands for anti-citrullinated protein antibodies — autoantibodies that mark the most aggressive, erosive form of rheumatoid arthritis; ACPA-positive RA has stronger genetic determinants than seronegative RA, where the A allele confers OR 0.80 (95% CI 0.66–0.96, P=0.015). This specificity makes biological sense: ACPA-positive RA is a more genetically driven, immune-mediated disease where A20 expression capacity directly constrains disease initiation and severity.

A meta-analysis of six studies⁷⁷ meta-analysis of six studies
Including 11,166 RA cases and 11,231 controls (11,166 cases / 11,231 controls) confirmed the protective association for GA vs GG genotype (OR 0.88, 95% CI 0.79–0.99, P=0.034) with the effect concentrated in Caucasian populations. No significant association was found in Asian or African-American populations, consistent with the lower A allele frequency in East Asian populations (~9.7% vs ~28% in Europeans).

Beyond RA, the rs13207033A–rs10499194T protective haplotype has been associated with reduced risk of ankylosing spondylitis⁸⁸ ankylosing spondylitis
A chronic inflammatory arthritis primarily of the spine and sacroiliac joints, classified as a spondyloarthropathy in Eastern Chinese Han populations (OR 0.60, 95% CI 0.42–0.87, P=0.006) — extending the protective signal beyond RA to other NF-kB-driven inflammatory arthritides.

The three-SNP model at 6q23 illustrates why individual variants tell only part of the story. The most dangerous haplotype combination — homozygous risk alleles at rs6920220 and rs5029937 with complete absence of the rs13207033 protective A allele — carries a combined OR of 1.86⁹⁹ combined OR of 1.86
95% CI 1.51–2.29, from formal three-SNP conditional analysis in 3,962 RA cases for RA, compared to OR 0.86 for the protective A allele alone.

Practical Implications

Carrying one or two copies of the A allele at rs13207033 is genetically favorable — it indicates greater capacity for NF-kB self-regulation via A20. For most A-allele carriers, this is a reassuring counterweight against other inflammatory risk factors. For homozygous GG carriers (lacking the protective allele entirely), the loss of this inherent protective signal is clinically meaningful primarily in the context of the companion 6q23 risk variants; as an isolated finding, GG genotype represents the common baseline population risk.

Two large-scale RCT interventions directly target the NF-kB pathway that A20 regulates. The VITAL trial¹⁰¹⁰ VITAL trial
A 5-year randomized controlled trial of 25,871 adults assigned to vitamin D3 2000 IU/day, omega-3 1 g/day, both, or placebo found vitamin D3 supplementation reduced incident autoimmune disease by 22% (HR 0.78, P=0.05) and omega-3 fatty acids reduced it by 15%. For GG carriers who lack the protective allele, these interventions represent the most evidence-backed approach to compensating for reduced genetic NF-kB braking capacity.

Interactions

rs13207033 is one of three statistically independent signals at the 6q23 locus. The other two — rs6920220 (intergenic, reduces TNFAIP3 transcription) and rs5029937 (intronic in TNFAIP3, also risk) — are independently inherited and their combination with rs13207033 genotype substantially alters overall RA risk. Carrying both risk alleles for the other two SNPs while being GG at rs13207033 (i.e., lacking the protective A allele) yields OR 1.86, the highest risk configuration at this locus.

The TNFAIP3 missense variant rs2230926 (F127C) operates through a different mechanism — impaired A20 enzymatic activity rather than altered expression — and is independent of the 6q23 haplotype block. Carriers of both the rs2230926 G risk allele and rs13207033 GG genotype lack both the quantitative (expression-level) and qualitative (enzyme-activity) components of A20 function, a combination that warrants a dedicated compound action assessment.